| TRI
Sections |
 |
SENIOR
TRI INVESTIGATORS AND ADMINISTRATORS
Section
on Treatment Systems Research
 Deni
Carise, Ph.D. is an expert in the organization and delivery of
treatment services in the nation’s substance abuse treatment system.
Developer of the White House-funded DENS™ data collection, assessment
and treatment support system, Dr. Carise designs data collection strategies
and training programs helping counselors introduce and measure evidence-based
practices in substance abuse treatment. She has been Principal Investigator
on numerous NIH-funded grants; her computer-assisted patient assessment
and referral system, “CASPAR,” funded by both NIDA and NIAAA,
has been demonstrated to increase matching of patients to the auxiliary
services they need for recovery. Her DENS™ and CASPAR work has been
replicated nationally and internationally in countries such as Thailand,
Nigeria, Egypt and others. Beginning 2010, Dr. Carise splits her time
between TRI and Phoenix House where she is Senior Vice-President and Chief
Clinical Officer. Dr Carise is an Adjunct Clinical Professor at the University
of Pennsylvania.
 Adam
C. Brooks, Ph.D. is a Research Scientist working on continuous
care and adaptive treatment protocols, along with performance-based contracting
strategies. Dr. Brooks has a Ph.D. in clinical psychology with a specialization
in marital and family therapy from St. John’s University. Prior
to joining TRI, he was at the Columbia University Division on Substance
Abuse where he treated substance abusing patients using a variety of empirically
validated treatments. He is an expert supervisor in Motivational Interviewing,
and part of a team at Columbia developing a teleconferenced form of supervision
for distance learning of the technique. His research interests include
computer-assisted treatment and training interventions, use of phone technology
in treatment and recovery monitoring, and workforce development in the
use of evidence-based practices.
 Amy
A. Mericle, Ph.D. Dr. Mericle received Bachelor’s of Arts
and Master’s of Social Work degrees from the University of Michigan.
Prior to receiving her doctoral degree from the University of Chicago,
she worked as a research assistant at the Northwestern University Psycho-Legal
Studies Program. Dr. Mericle’s dissertation examined HIV/AIDS risk
behavior among participants in the Northwestern Juvenile Project, a longitudinal
study led by Linda Teplin, Ph.D. examining the mental health and substance
abuse service needs and service use of detained adolescents. After completing
her doctoral degree, Dr. Mericle accepted a post-doctoral fellowship at
the University of California’s San Francisco Treatment Research
Center where she worked with Barbara Havassy, Ph.D. examining violence
and social networks among individuals with co-occurring mental and substance
use disorders. Dr. Mericle is currently working with Deni Carise, Ph.D.
and is Principal Investigator on TRI’s Detection, Advice, Referral
To Services (DARTS) project. Her research interests include co-occurring
disorders and complications of substance abuse, social networks and treatment
seeking, and treatment linkage among disparate systems of care. Dr. Mericle
is a member (in training) of the College for Problems of Drug Dependence
and the American Public Health Association. She holds a diplomate in measurement
from the Institute of Objective Measurement.
Treatment
Research Solutions Group
 Ms.
Meghan Love, Senior Program Manager, has significant past project
experience that includes management of counselor training studies on electronic
resource guides linking substance abuse patients to low-cost auxiliary
services (NIDA and NIAAA funding), and coordination of a NIDA R21 Exploratory
Grant evaluating a concurrent recovery monitoring project in the state
of Delaware. From 1998 to 2004 she managed the ONDCP-funded DENS project,
a multi-site electronic data collection and reporting system that tracked
patterns of drug and alcohol abuse across the nation. Other NIDA-funded
studies she managed include, in collaboration with the University of Pennsylvania,
a study of patient-treatment matching utilizing the ASI as the primary
data collection tool; development of an Employee Assistance Program survey
estimating the prevalence of drug and alcohol abuse in school and workplace
populations; and development of the Substance Abuse Relapse Reduction
System (SARRS) for early detection of individuals at high risk for relapse
during the critical first six months of the post-treatment recovery period.
The empirically-developed products and services Ms. Love has helped TRI
introduce include the Risk and Needs Triage™ helping court officials
assign drug-involved offenders to the appropriate disposition; TRI-CEP™,
a web-based system to adaptively manage clients and conduct problem-solving
court evaluation; and CASPAR-C™, an electronic patient assessment
and referral system.
 Van
Lam, Web Product Developer, provides technical
leadership to teams of researchers, administrators and other specialists
on science-based product development. He also serves as technical liaison
to state and local government purchasers for adaptive, support and training
functions. Mr. Lam led technical development of TRI’s Risk and Needs
Triage™, TRI-CEP™, and CASPAR-C™, a software application
helping treatment counselors create a searchable database of patient services
available in their area. He was senior developer for the ONDCP-funded
DENS™, an ASI-based patient assessment tool linking client assessment
to treatment planning. Other pending projects include an electronic decision
support system enabling continuous recovery monitoring at the provider
level. Mr. Lam joined TRI in 1996 following other positions in the Philadelphia
area at Merck Pharmaceuticals and Corning-Besselaar. He is a 2002 graduate
of Drexel University where he earned a Bachelor of Science in Computer
Science.
|